21 results found
Location: About Us > College News The Department of Health has requested that we share the following information with College members regarding the Department's efforts to ensure that Irish patients have continued access to effective and appropriate health services and treatments. 1k · 21 October 2019 · Members Only
Location: Library & Publications > Public Health As you may be aware, there is an on-going intermittent shortage of supply of tamoxifen in Ireland. This is being caused by an international shortage of the active pharmaceutical ingredient. It is not related to Brexit. 374 bytes · 14 October 2019 · Members Only
Location: Education > Women's Health Programme > News Important information has emerged regarding the risks of prescribing sodium valproate (Epilim) to women of childbearing age. 2k · 1 December 2015 · Members Only
Location: Library & Publications > Newsletters > HPRA Newsletter
(No summary)
Members Only
Location: Library & Publications > Public Health In September 2019, at the request of the European Commission, the European Medicines Agency's safety committee (the Pharmacovigilance Risk Assessment Committee - PRAC) commenced a review of data on skin cancer in patients using Picato (ingenol mebutate), a gel indicated for the treatment of cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults. The product information includes a warning in relation to keratoacanthoma and was updated to also include basal cell ca 2k · 20 January 2020 · Members Only
Location: Library & Publications > Public Health The European Medicines Agency's safety committee (PRAC) has concluded a review of Xeljanz (tofacitinib) and recommended updates to product information and new risk minimisation measures. 5k · 4 November 2019 · Members Only
Location: Library & Publications > Resources List of useful links and websites. 6k · 10 June 2008 · Members Only
Location: Education > Women's Health Programme > News On July 24 2014, the European Medicines Agency (EMA) released a review entitled 'Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight'. 5k · 5 August 2014 · Members Only
Location: In Practice > IT in Practice > GPIT > Publications & Reports Healthmail Evaluation Report, research by the ICGP on the secure clinical email service of the HSE. 150 bytes · 31 July 2019 · Members Only
Location: Research > Research Ethics Please submit your application through the ICGP Vidatum software four weeks prior to the meeting i.e by the deadline submission date. 8k · 26 April 2017 · Members Only